Release Date: 25/11/16 10:10 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 830.3KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%